Lv1
20 积分 2024-10-31 加入
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism
7小时前
已完结
Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
12天前
已完结
Requirement for Cyclin D1 Underlies Cell Autonomous HIF2-Dependence in Kidney Cancer
16天前
已完结
Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia
21天前
已完结
Requirement for Cyclin D1 Underlies Cell Autonomous HIF2-Dependence in Kidney Cancer
22天前
已完结
Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinoma
1个月前
已完结
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
1个月前
已完结
Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
1个月前
已完结
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
1个月前
已完结
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
1个月前
已完结
皖公网安备34019202002308
